Avri Havron
Director/Board Member bei COLLPLANT BIOTECHNOLOGIES LTD.
Vermögen: - $ am 31.03.2024
Profil
Abraham Havron is currently a Director and Independent Director at CollPlant Ltd., CollPlant Biotechnologies Ltd., and Enlivex Therapeutics Ltd.
respectively.
He previously served as the Chief Executive Officer & Director at OPKO Biologics Ltd.
and Prolor Biotech Ltd.
from 2005 to 2013.
He was also an Independent Director at Kamada Ltd.
from 2010 to 2018 and an Independent External Director at MediWound Ltd.
from 2014 to 2017.
Prior to that, he was the Director-Research & Development at Interpharm Laboratories Ltd.
from 1980 to 1987 and Vice President-Manufacturing & Process Development at Biotechnology General (Israel) Ltd.
from 1987 to 1999.
He also served as the Chief Technology Officer & Vice President at Clal Biotechnology Industries Ltd.
from 1999 to 2003.
He holds an undergraduate degree from The Hebrew University of Jerusalem and a doctorate from Weizmann Institute of Science.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Avri Havron
| Unternehmen | Position | Beginn |
|---|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Director/Board Member | 01.05.2016 |
| ENLIVEX THERAPEUTICS LTD. | Director/Board Member | 01.01.2014 |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Director/Board Member | 01.05.2016 |
Ehemalige bekannte Positionen von Avri Havron
| Unternehmen | Position | Ende |
|---|---|---|
Pam-Bio Ltd.
 Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Director/Board Member | 01.01.2019 |
| KAMADA LTD. | Director/Board Member | 20.12.2018 |
| MEDIWOUND LTD. | Director/Board Member | 22.06.2017 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Chief Executive Officer | 01.01.2013 |
Prolor Biotech Ltd.
 Prolor Biotech Ltd. BiotechnologyHealth Technology Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel. | Chief Executive Officer | 01.01.2013 |
Ausbildung von Avri Havron
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| KAMADA LTD. | Health Technology |
| MEDIWOUND LTD. | Health Technology |
| COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
CollPlant Ltd.
CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Health Technology |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The private company is based in Rehovot, Israel. The company was founded by Israel Makov. | Health Technology |
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
Pam-Bio Ltd.
Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Health Technology |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel. | Health Technology |
